These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10099663)

  • 1. Role of radiation therapy in parameningeal rhabdomyosarcoma.
    Paulino AC
    Cancer Invest; 1999; 17(3):223-30. PubMed ID: 10099663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.
    Spalding AC; Hawkins DS; Donaldson SS; Anderson JR; Lyden E; Laurie F; Wolden SL; Arndt CA; Michalski JM
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):512-6. PubMed ID: 24074925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas.
    Michalski JM; Sur RK; Harms WB; Purdy JA
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):985-91. PubMed ID: 7493860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation and chemotherapy of parameningeal rhabdomyosarcoma involving the orbit.
    Haik BG; Jereb B; Smith ME; Ellsworth RM; McCormick B
    Ophthalmology; 1986 Aug; 93(8):1001-9. PubMed ID: 3763144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic involvement as a presenting feature of nonorbital childhood parameningeal embryonal rhabdomyosarcoma.
    Mullaney PB; Nabi NU; Thorner P; Buncic R
    Ophthalmology; 2001 Jan; 108(1):179-82. PubMed ID: 11150285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation.
    Paulino AC; Bauman N; Simon JH; Nguyen TX; Ritchie JM; Tannous R
    Med Pediatr Oncol; 2003 Aug; 41(2):118-22. PubMed ID: 12825215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Study Group.
    Walterhouse DO; Pappo AS; Baker KS; Parham DM; Anderson JR; Donaldson SS; Paidas CN; Womer RB; Crist WM
    Cancer; 2001 Dec; 92(12):3135-46. PubMed ID: 11753993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
    Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
    Raney RB; Tefft M; Newton WA; Ragab AH; Lawrence W; Gehan EA; Maurer HM
    Cancer; 1987 Jan; 59(1):147-55. PubMed ID: 3791141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameningeal rhabdomyosarcoma: results of an international workshop.
    Benk V; Rodary C; Donaldson SS; Flamant F; Maurer H; Treuner I; Carli M; Gehan E
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):533-40. PubMed ID: 8948336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameningeal rhabdomyosarcoma in the young.
    Berry MP; Jenkin RD
    Cancer; 1981 Jul; 48(2):281-8. PubMed ID: 7237399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone deficiency following radiotherapy for orbital and parameningeal sarcomas.
    Goddard AG; Harris SJ; Plowman PN; Savage MO; Kingston JE
    Pediatr Hematol Oncol; 1999; 16(1):23-33. PubMed ID: 9932270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.
    Regine WF; Fontanesi J; Kumar P; Ayers D; Bowman LC; Pappo AS; Coffey DH; Avery L; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):485-91. PubMed ID: 7852110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study.
    Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma.
    Raney B; Tefft M; Heyn R; Newton W; Jones PM; Haeberlen V; Maurer H
    Cancer; 1992 Mar; 69(6):1498-506. PubMed ID: 1540886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival.
    Eaton BR; McDonald MW; Kim S; Marcus RB; Sutter AL; Chen Z; Esiashvili N
    Cancer; 2013 Apr; 119(8):1578-85. PubMed ID: 23280478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
    Wolden SL; Wexler LH; Kraus DH; Laquaglia MP; Lis E; Meyers PA
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1432-8. PubMed ID: 15817347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.